Skip to main content

Table 3 Highly connected modules identified at PPI networks and enrichment analysis of each module

From: Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer

Subnetwork A (TT vs. NT)

Module

Genes

KEGG pathways

p-value

Module 1

ANLN, BUB1, CCNA2, CCNB1, CCNB2, CCND1, CCNE2 CDK1, CDKN2A, CDKN2C, CDKN3, CKS2, DLGAP5, E2F3, ECT2, FOXM1, KIF11, KIF20A, KIF23, MELK, MKI67, NCAPG, NUF2, PARP1, PLK1, PRC1, RACGAP1, RRM2, RRM2B, SMC4, SNCG, SPC25, TOP2A, TP63, TPX2, TTK, ZWINT

Cell cycle

Cellular senescence

p53 signaling pathway

Viral carcinogenesis

Pathways in cancer

7.75E-67

8.59E-26

3.81E-23

3.56E-19

1.25E-12

Module 2

ARHGAP35, BLNK, CAV1, CAV2, CDH1, CLEC3B, CTNNA1, EGFR, ERBB3, FNBPIL, GRB2, KALRN, KIT, MET, MME, MMP9, NRG1, PDGFD, PIK3R1, PIK3R3, PREX1, PTPRJ, SGIP1, SORBS1, SPRY1 SPRY2, TNS1, VEGFC

ErbB signaling pathway

EGFR tyrosine kinase inhibitor resistance

Focal adhesion

Ras signaling pathway

Proteoglycans in cancer

2.95E-47

1.13E-39

1.68E-36

3.57E-36

2.08E-28

Module 3

ACVR1C, AMOTL1, AR, CDH11, CDH3, ESR1, EZH1, EZH2, FOXA1, HDAC1, NCOA7, NR3C1, PPARG, PPARGC1A, RUNX2, SKIL, SNAI2, SOX6, STMN1, VTCF7L2, THRA, TLE4, ZBTB16, ZEB2

Transcriptional misregulation in cancer

Thyroid hormone signaling pathway

Pathways in cancer

Signaling pathways regulating pluripotency of stem cells

Adherens junction

1.02E-14

1.30E-11

4.54E-11

1.91E-08

2.78E-07

Subnetwork B (PT vs. NT)

Module

Genes

KEGG pathways

p-value

Module 1

ANLN, ARHGAP11A, BUB1, CCND1, CCNF, CDK1, CDKN2A, CDKN2C CDKN3, CENPF, DLGAP5, E2F3, KIF18A, KIF20A, KIF23, MKI67, PRC1, RCC2, RRM2, SNCG, TOP2A, TTK

Cell cycle

Viral carcinogenesis

Cellular senescence

p53 signaling pathway

Steroid hormone biosynthesis

2.27E-77

9.98E-21

1.51E-16

1.05E-15

8.53E-07

Module 2

ADGRA2, CAV1, CAV2, CDH11, DLG5, DOCK10, FN1, GSN, KALRN, MET, NTRK2, NTRK3, PAK3, PRKAR2B, PTPRJ, RAB4B, S100A4, SORBS1, SPINT2, TCN1 TNS1, VCAN

Focal adhesion

Ras signaling pathway

Proteoglycans in cancer

PI3K-Akt signaling pathway

Regulation of actin cytoskeleton

8.44E-42

1.97E-34

1.18E-30

4.22E-26

4.45E-25

Module 3

BMPR1B, CHRDL1, INHBA, RGMA, SOSTDC1, TFGBR1, TGFBR3

TGF-beta signaling pathway

Hippo signaling pathway

Cytokine-cytokine receptor interaction

Signaling pathways regulating pluripotency of stem cells

Steroid hormone biosynthesis

2.91E-51

1.63E-16

4.34E-16

2.84E-10

8.09E-10

  1. TT: Tumoral Tissue, PT: Peritumoral Tissue, and NT: Non-tumoral Tissue